PeptideDB

(R)-BAY-85-8501 2446175-39-7

(R)-BAY-85-8501 2446175-39-7

CAS No.: 2446175-39-7

(R)-BAY-85-8501 is the less active enantiomer of BAY-85-8501. BAY-85-8501 is a potent and specific inhibitor of human ne
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

(R)-BAY-85-8501 is the less active enantiomer of BAY-85-8501. BAY-85-8501 is a potent and specific inhibitor of human neutral lipase (HNE) with IC50 of 65 pM.

Physicochemical Properties


Molecular Formula C22H17F3N4O3S
Molecular Weight 474.4556
Exact Mass 474.097
CAS # 2446175-39-7
Related CAS # BAY-85-8501;1161921-82-9
PubChem CID 137704648
Appearance White to off-white solid powder
LogP 2.6
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 8
Rotatable Bond Count 3
Heavy Atom Count 33
Complexity 1030
Defined Atom Stereocenter Count 1
SMILES

CC1=C([C@@H](N(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C)C3=C(C=C(C=C3)C#N)S(=O)(=O)C)C#N

InChi Key YAJWYFPMASPAMM-FQEVSTJZSA-N
InChi Code

InChI=1S/C22H17F3N4O3S/c1-13-18(12-27)20(17-8-7-14(11-26)9-19(17)33(3,31)32)28(2)21(30)29(13)16-6-4-5-15(10-16)22(23,24)25/h4-10,20H,1-3H3/t20-/m0/s1
Chemical Name

(4R)-4-(4-cyano-2-methylsulfonylphenyl)-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-4H-pyrimidine-5-carbonitrile
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Freezing the Bioactive Conformation to Boost Potency: The Identification of BAY 85-8501, a Selective and Potent Inhibitor of Human Neutrophil Elastase for Pulmonary Diseases. ChemMedChem. 2015 Jul;10(7):1163-73.


Solubility Data


Solubility (In Vitro) DMSO: 100 mg/mL (210.77 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (5.27 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (5.27 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.1077 mL 10.5383 mL 21.0766 mL
5 mM 0.4215 mL 2.1077 mL 4.2153 mL
10 mM 0.2108 mL 1.0538 mL 2.1077 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.